BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3519242)

  • 21. Metergoline as an alternative to bromocriptine in amenorrhoea.
    Hicks BH; Finer N; Herbert LC
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural mechanisms in primary hypertension. Efficacy of alpha-blockade with doxazosin during stress.
    Lee D; Lu ZW; DeQuattro V
    Am J Hypertens; 1996 Jan; 9(1):47-53. PubMed ID: 8834706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromocriptine treatment of spasmodic torticollis. A double-blind crossover study.
    Juntunen J; Kaste M; Iivanainen M; Ranta T; Seppälä M
    Arch Neurol; 1979 Jul; 36(7):449-50. PubMed ID: 378199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
    Jamieson M; Petrie JC; Webster J; Miller A; Harris RI; Francis RJ
    Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocriptine and norethisterone in the treatment of premenstrual syndrome.
    Ylöstalo P; Kauppila A; Puolakka J; Rönnberg L; Jänne O
    Obstet Gynecol; 1982 Mar; 59(3):292-8. PubMed ID: 6804900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
    Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
    Rumboldt Z; Rumboldt M; Jurisic M
    Curr Med Res Opin; 1984; 9(1):10-20. PubMed ID: 6373155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No effect of bromocriptine in acromegaly: a controlled trial.
    Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
    N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the effects of bromocriptine on sexual impotence.
    Ambrosi B; Bara R; Travaglini P; Weber G; Beck Peccoz P; Rondena M; Elli R; Faglia G
    Clin Endocrinol (Oxf); 1977 Nov; 7(5):417-21. PubMed ID: 338206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amlodipine: a double-blind evaluation of the dose-response relationship in mild to moderate hypertension.
    Frick MH; McGibney D; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S76-8. PubMed ID: 2467135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin suppression in the treatment of premenstrual syndrome.
    Graham JJ; Harding PE; Wise PH; Berriman H
    Med J Aust; 1978 Nov; 2(3 Suppl):18-20. PubMed ID: 370525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary function in normoprolactinaemic infertile men receiving bromocriptine.
    Glatthaar C; Donald RA; Smith R; McRae CU
    Clin Endocrinol (Oxf); 1980 Nov; 13(5):455-9. PubMed ID: 6784976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.
    Neutel JM; Buckalew V; Chrysant SG; Mroczek WJ; Ruff DA; Weber M
    Am Heart J; 1999 Jan; 137(1):118-25. PubMed ID: 9878944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the antihypertensive activities of xipamide and chlorthalidone: a double-blind, randomized, crossover trial.
    Bonaduce D; Ferrara N; Petretta M; Canonico V; Romango E; Rengo F
    Curr Med Res Opin; 1981; 7(4):247-52. PubMed ID: 7014105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
    Glazener CM; Kelly NJ; Hull MG
    Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.